MICHAEL VOLK to Liver Transplantation
This is a "connection" page, showing publications MICHAEL VOLK has written about Liver Transplantation.
Connection Strength
7.916
-
Lung cancer screening among liver transplant recipients. Liver Transpl. 2023 10 01; 29(10):1025-1026.
Score: 0.431
-
Measuring the Toll of Acute Illness-Derived Frailty in Decompensated Cirrhosis. Liver Transpl. 2021 12; 27(12):1701-1703.
Score: 0.385
-
Positron Emission Tomography Scan in Detecting and Locating Extrahepatic Recurrent Hepatocellular Carcinoma Post Orthotic Liver Transplant. Prog Transplant. 2020 12; 30(4):396-397.
Score: 0.361
-
Constitutional Challenges to Liver Transplant Policy. Transplantation. 2019 11; 103(11):e378-e381.
Score: 0.340
-
Cardiovascular Complications After Liver Transplant: A Shifting Clinical Presentation. Liver Transpl. 2018 10; 24(10):1331-1332.
Score: 0.315
-
Transplantation for Alcohol-related Liver Disease: Is It Fair? Alcohol Alcohol. 2018 Mar 01; 53(2):173-177.
Score: 0.303
-
Maximizing the benefit of liver transplantation: Implications for organ allocation and clinical practice. Transplant Rev (Orlando). 2016 Jan; 30(1):1-2.
Score: 0.261
-
Analytic morphomics identifies predictors of new-onset diabetes after liver transplantation. Clin Transplant. 2015 May; 29(5):458-64.
Score: 0.248
-
Patient preferences about organ offers in liver transplantation. Liver Transpl. 2015 Jan; 21(1):140-1.
Score: 0.243
-
Pilot test of a patient decision aid about liver transplant organ quality. Liver Transpl. 2014 Jul; 20(7):850-5.
Score: 0.235
-
Center differences in model for end-stage liver disease exceptions: fairness, local culture, and norms of practice. Liver Transpl. 2013 Dec; 19(12):1287-8.
Score: 0.223
-
Systematic bias in surgeons' predictions of the donor-specific risk of liver transplant graft failure. Liver Transpl. 2013 Sep; 19(9):987-90.
Score: 0.221
-
Non-adherence and graft failure in adult liver transplant recipients. Dig Dis Sci. 2013 Mar; 58(3):824-34.
Score: 0.208
-
Declined organ offers in liver transplantation: careful timing or missed opportunity? Gastroenterology. 2012 Nov; 143(5):1141-1143.
Score: 0.208
-
Organ quality and quality of life after liver transplantation. Liver Transpl. 2011 Dec; 17(12):1443-7.
Score: 0.196
-
Patient decision making about organ quality in liver transplantation. Liver Transpl. 2011 Dec; 17(12):1387-93.
Score: 0.196
-
Decision making in liver transplant selection committees: a multicenter study. Ann Intern Med. 2011 Oct 18; 155(8):503-8.
Score: 0.195
-
Variation in organ quality between liver transplant centers. Am J Transplant. 2011 May; 11(5):958-64.
Score: 0.188
-
Geographic variation in organ availability is responsible for disparities in liver transplantation between Hispanics and Caucasians. Am J Transplant. 2009 Sep; 9(9):2113-8.
Score: 0.166
-
Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation. Gastroenterology. 2008 Nov; 135(5):1568-74.
Score: 0.159
-
Beyond utilitarianism: a method for analyzing competing ethical principles in a decision analysis of liver transplantation. Med Decis Making. 2008 Sep-Oct; 28(5):763-72.
Score: 0.157
-
Liver transplantation for hepatocellular carcinoma: who benefits and who is harmed? Gastroenterology. 2008 May; 134(5):1612-4.
Score: 0.153
-
A novel model measuring the harm of transplanting hepatocellular carcinoma exceeding Milan criteria. Am J Transplant. 2008 Apr; 8(4):839-46.
Score: 0.151
-
Modified Charlson comorbidity index for predicting survival after liver transplantation. Liver Transpl. 2007 Nov; 13(11):1515-20.
Score: 0.148
-
Who decides? Living donor liver transplantation for advanced hepatocellular carcinoma. Transplantation. 2006 Nov 15; 82(9):1136-9.
Score: 0.138
-
The Liver Transplant Comorbidity Index (LTCI): A composite index of ambulatory pre-LT factors to identify patients at increased risk of post-LT mortality. Hepatology. 2026 Feb 01; 83(2):294-303.
Score: 0.123
-
Liver transplantation provides survival benefit at all levels of frailty: From the Multicenter Functional Assessment in Liver Transplantation Study. Hepatology. 2025 Apr 01; 81(4):1269-1275.
Score: 0.118
-
Quality measures in pre-liver transplant care by the Practice Metrics Committee of the American Association for the Study of Liver Diseases. Hepatology. 2024 09 01; 80(3):742-753.
Score: 0.115
-
The liver frailty index is a predictor of healthcare utilization after liver transplantation in older adults. Clin Transplant. 2024 01; 38(1):e15219.
Score: 0.113
-
Outcomes and Resource Utilization in Liver Transplant Recipients Who Underwent Expedited Transplant Evaluation. Prog Transplant. 2023 09; 33(3):223-228.
Score: 0.110
-
Loneliness in adults awaiting liver transplantation at 7 U.S. transplant centers. Ann Hepatol. 2022 Sep-Oct; 27(5):100718.
Score: 0.101
-
Frailty, mortality, and health care utilization after liver transplantation: From the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study. Hepatology. 2022 06; 75(6):1471-1479.
Score: 0.099
-
Utility of Framingham Score for Optimizing Preoperative Evaluation Among Patients Undergoing Liver Transplant Evaluation. Transplant Proc. 2021 Jun; 53(5):1616-1621.
Score: 0.094
-
Association of Frailty and Sex With Wait List Mortality in Liver Transplant Candidates in the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study. JAMA Surg. 2021 03 01; 156(3):256-262.
Score: 0.093
-
Identifying an Optimal Liver Frailty Index Cutoff to Predict Waitlist Mortality in Liver Transplant Candidates. Hepatology. 2021 03; 73(3):1132-1139.
Score: 0.091
-
A 2020 update on liver transplant for hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol. 2020 Oct; 14(10):885-900.
Score: 0.090
-
Predictors of Systolic Heart Failure and Mortality Following Orthotopic Liver Transplantation: a Single-Center Cohort. Transplant Proc. 2019 Jul - Aug; 51(6):1950-1955.
Score: 0.083
-
Palliative care and end-stage liver disease: a critical review of current knowledge. Curr Opin Gastroenterol. 2019 05; 35(3):155-160.
Score: 0.082
-
Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multicenter Study. Gastroenterology. 2019 05; 156(6):1675-1682.
Score: 0.080
-
Factors Associated with Survival of Patients With Severe Acute-On-Chronic Liver Failure Before and After Liver?Transplantation. Gastroenterology. 2019 Apr; 156(5):1381-1391.e3.
Score: 0.080
-
Controversies in early liver transplantation for severe alcoholic hepatitis. Ann Hepatol. 2018 Aug 24; 17(5):759-768.
Score: 0.078
-
Analysis of Liver Offers to Pediatric Candidates on the Transplant Wait List. Gastroenterology. 2017 10; 153(4):988-995.
Score: 0.072
-
Cost-Effectiveness of Direct-Acting Antiviral Treatment in Hepatitis C-Infected Liver Transplant Candidates With Compensated Cirrhosis and Hepatocellular Carcinoma. Transplantation. 2017 05; 101(5):1001-1008.
Score: 0.071
-
Estimation of Liver Transplant Related Survival Benefit: the Devil Is in The Details. Gastroenterology. 2016 Feb; 150(2):534-5.
Score: 0.065
-
Neoadjuvant stereotactic body radiation therapy, capecitabine, and liver transplantation for unresectable hilar cholangiocarcinoma. Liver Transpl. 2014 Jan; 20(1):81-8.
Score: 0.056
-
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list. J Hepatol. 2014 Feb; 60(2):290-7.
Score: 0.056
-
Clinical yield of diagnostic endoscopic retrograde cholangiopancreatography in orthotopic liver transplant recipients with suspected biliary complications. Liver Transpl. 2012 Dec; 18(12):1479-84.
Score: 0.053
-
Is MRCP equivalent to ERCP for diagnosing biliary obstruction in orthotopic liver transplant recipients? A meta-analysis. Gastrointest Endosc. 2011 May; 73(5):955-62.
Score: 0.046
-
Estimation of the harm to the waiting list as a crucial factor in the selection of patients with hepatocellular carcinoma for liver transplantation. Transplant Proc. 2010 May; 42(4):1194-6.
Score: 0.044
-
The survival benefit of liver transplantation in hepatocellular carcinoma patients. Dig Liver Dis. 2010 Sep; 42(9):642-9.
Score: 0.044
-
Performance-Based Measures Associate With Frailty in Patients With End-Stage Liver Disease. Transplantation. 2016 Dec; 100(12):2656-2660.
Score: 0.017
-
Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost-benefit analysis while awaiting data on sorafenib safety. Hepatology. 2010 Jan; 51(1):165-73.
Score: 0.011